Low vital capacity is associated with diabetes despite inverse relationships with metabolic risk factors in lean Japanese men

Internal Medicine

Volumn 48, Issue 14, 2009, Pages 1201-1207

  Oda, Eiji ^a   Kawai, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Diabetes; Lean men; Metabolic syndrome; Vital capacity

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; INSULIN RESISTANCE; JAPANESE; LEAN BODY WEIGHT; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAL CAPACITY; WAIST CIRCUMFERENCE;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; VITAL CAPACITY;

EID: 70349524696     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2085     Document Type: Article

References (19)

1. Lazarus R, Sparrow D, Weiss ST. Baseline ventilator function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 12: 641-645, 1998.
2. Engstrom G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 19: 167-170, 2002.
3. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 253: 574-581, 2003.
4. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes. Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27: 2966-2970, 2004.
5. Yeh H, Punjabi NM, Wang N, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes Care 28: 1472-1479, 2005.
6. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
7. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
8. Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 134: 712-718, 2008.
9. Sakuta H, Suzuki T, Yasuda H, Ito T. Vital capacity and selected metabolic diseases in middle-aged Japanese men. Can Resp J 13: 79-82, 2006.
10. Oda E, Kawai R. A cross-sectional relationship between vital capacity and diabetes in Japanese men. Diabetes Res Clin Pract 85: 111-116, 2009.
11. Gerich JE. Contribution of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78: 447-456, 2003.
12. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
13. Chance WW, Rhee C, Yilmaz C, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31: 1596-1601, 2008.
14. Yeh H, Punjabi NM, Wang N, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes. Diabetes Care 31: 741-746, 2008.
15. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454, 2005.
16. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.
17. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31: 1285-1293, 2008.
18. Fernandez-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W. Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care 31: 958-963, 2008.
19. Harita N, Hayashi T, Kogawa-Sato K, Nakamura Y, Yoneda T, Endo G. Lower serum creatinine is a new risk factor of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care 32: 424-426, 2009.